Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03251937 · ClinicalTrials.gov registry record · NA
Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
NCT03251937 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 97 participants.
The verdict
NCT03251937, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
Study Summary
To demonstrate the value of multiple modalities and sustained clinically significant pain relief in patients with chronic pain when using the Boston Scientific Spectra WaveWriter Spinal Cord Stimulator (SCS) System.
Interventions
- DEVICE Spectra WaveWriter SCS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2020-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03251937
The ClinicalTrials.gov registry entry for NCT03251937 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spectra WaveWriter SCS System is the first listed.
NCT03251937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03251937 about?
NCT03251937 is a clinical study titled "Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System". To demonstrate the value of multiple modalities and sustained clinically significant pain relief in patients with chronic pain when using the Boston Scientific Spectra WaveWriter Spinal Cord Stimulator (SCS) System.
What is the current status of trial NCT03251937?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2018-01-09. Estimated completion is 2020-03-10.
What interventions are being tested in trial NCT03251937?
The interventions under investigation include: Spectra WaveWriter SCS System (DEVICE).
Who is sponsoring clinical trial NCT03251937?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.